DDR2 has been shown to be a cancer-related gene associated with prostate cancer aggressiveness and progression, and its expression is upregulated in advanced benign prostate hyperplasia and prostate cancer compared to normal tissue [51]. The gene discussed is DDR2; the disease is prostate carcinoma.